Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00819598 · ClinicalTrials.gov registry record

Pilot Study to Determine the Optimal Technique for Measurement of Ankle Blood Pressures

A clinical trial of Peripheral Arterial Disease, sponsored by Summit Doppler Systems.

Completed
Registry status
70
Enrollment target
1
Study location

NCT00819598: Completed study of Peripheral Arterial Disease, sponsored by Summit Doppler Systems.

NCT00819598 is a study of Peripheral Arterial Disease that has completed, run by Summit Doppler Systems. The registered enrollment target is 70 participants, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00819598, a study of Peripheral Arterial Disease, has completed, sponsored by Summit Doppler Systems.

COMPLETED
Registry status
70 participants
Enrollment target
1
Study location

Study Summary

Peripheral arterial disease (PAD) is a highly prevalent medical condition. Patients with PAD are usually diagnosed on the basis of the ankle-brachial index. The ankle-brachial index is the ratio of ankle pressure to arm pressure based on measurement of blood pressures in the arms and legs using a Doppler device. The need for dedicated equipment and trained personnel, along with the time required to perform the test, have been identified as barriers to widespread implementation of ankle-brachial index screening. The use of automated oscillometric devices for blood pressure measurement and determination of the ankle-brachial index has been applied with variable success. It will be beneficial to investigate a reliable oscillometric-based procedure that can accurately measure leg pressures for the ankle-brachial index across the entire spectrum of PAD severity. The purpose of this study is to determine the optimal oscillometric-based technique for estimation of Doppler-derived systolic arm and ankle blood pressures for calculation of the ankle-brachial index in patients with and without PAD. Subjects with suspected arterial disease in the non-invasive lab will be enrolled. Arm, ankle, and toe pressure measurements will be made in the supine position using Doppler, oscillometric methods, and photoplethysmographic sensor. Arm and ankle pressures from a subset of subjects will be obtained in both seated and supine positions. The ankle-brachial index and toe-brachial index will be calculated.

Interventions

  • PROCEDURE BLOOD PRESSURE MEASURMENT
  • PROCEDURE BLOOD PRESSURE MEASUREMENT

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2009-01
Est. Completion 2009-10
Summit Doppler Systems

2 total trials

What the finished NCT00819598 record still lists

NCT00819598 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which BLOOD PRESSURE MEASURMENT is the first listed.

NCT00819598 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT00819598 about?

NCT00819598 is a clinical study titled "Pilot Study to Determine the Optimal Technique for Measurement of Ankle Blood Pressures". Peripheral arterial disease (PAD) is a highly prevalent medical condition. Patients with PAD are usually diagnosed on the basis of the ankle-brachial index. The ankle-brachial index is the ratio of ankle pressure to arm pressure based on measurement of blood pressures in the arms and legs using a Do...

What is the current status of trial NCT00819598?

This trial is currently completed. The enrollment target is 70 participants. The study started on 2009-01. Estimated completion is 2009-10.

What conditions does trial NCT00819598 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT00819598?

The interventions under investigation include: BLOOD PRESSURE MEASURMENT (PROCEDURE), BLOOD PRESSURE MEASUREMENT (PROCEDURE).

Who is sponsoring clinical trial NCT00819598?

This trial is sponsored by Summit Doppler Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00819598 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00819598's enrollment target sits among peer trials

70 45th of 79 higher than 33 of 79 other Peripheral Arterial Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00819598, the US trial registry maintained by the National Library of Medicine. NCT00819598 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.